Indefinite Delivery Contract SPE2DX15D9502

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,999,999 single-award IDC, valid through December 2025, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

The contract covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This allows DMS Pharmaceutical Group to serve as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. The delivery orders issued to date, valued between $2 and $9,706, have primarily been for specialized medications including Xolair, Trikafta, Keytruda, Botox, and Nucala.